Sermonix Launches Phase 2 Trial to Evaluate Investigational Oral Lasofoxifene as a Targeted Precision Treatment for Women With ESR1 Mutations in Metastatic Breast Cancer COLUMBUS, Ohio, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals LLC, a privately held biopharmaceutical company focused on the development and commercialization of female-specific...

Advanced Radiation Therapy Selects Theragenics Corporation to Distribute Its AccuBoost Technology TYNGSBORO, Mass., July 30, 2015 (GLOBE NEWSWIRE) -- Advanced Radiation Therapy, developer of the AccuBoost targeted partial breast irradiation technology, announced today that it has reached an...

Florida Blue Partners With My Hope Chest for Pilot Workshops ST. PETERSBURG, FL--(Marketwired - Aug 1, 2014) - In a collaborative effort, Florida Blue Westshore Retail Store will partner with My Hope Chest, the locally based national charity, to launch, "Sex,...

Introducing The BC5 Project: New Initiative to Empower Women to Explore All Breast Cancer Treatment Options NEW YORK, Sept. 10, 2013 (GLOBE NEWSWIRE) -- In an effort to ensure that all women diagnosed with early stage breast cancer are well-informed about their treatment options, a new group called The BC5...

My Hope Chest Debuts 1st Official Breast Reconstruction Ribbon SEMINOLE, FL--(Marketwired - Aug 20, 2013) - My Hope Chest, the only non-profit organization in the nation that offers assistance in obtaining breast reconstruction surgery for the uninsured and...